| ［1］ |
Kaufman BP, Aman T, Alexis AF. Postinflammatory hyperpigmentation: epidemiology, clinical presentation, pathogenesis and treatment［J］. Am J Clin Dermatol, 2018,19（4）:489⁃503. doi: 10.1007/s40257⁃017⁃0333⁃6.
|
| ［2］ |
Davis EC, Callender VD. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color［J］. J Clin Aesthet Dermatol, 2010,3（7）:20⁃31.
|
| ［3］ |
Perkins AC, Cheng CE, Hillebrand GG, et al. Comparison of the epidemiology of acne vulgaris among Caucasian, Asian, Continental Indian and African American women［J］. J Eur Acad Dermatol Venereol, 2011,25（9）:1054⁃1060. doi: 10.1111/j.1468⁃3083.2010.03919.x.
|
| ［4］ |
Chan HH, Manstein D, Yu CS, et al. The prevalence and risk factors of post⁃inflammatory hyperpigmentation after fractional resurfacing in Asians［J］. Lasers Surg Med, 2007,39（5）:381⁃385. doi: 10.1002/lsm.20512.
|
| ［5］ |
Manuskiatti W, Triwongwaranat D, Varothai S, et al. Efficacy and safety of a carbon⁃dioxide ablative fractional resurfacing device for treatment of atrophic acne scars in Asians［J］. J Am Acad Dermatol, 2010,63（2）:274⁃283. doi: 10.1016/j.jaad.2009. 08.051.
|
| ［6］ |
Chapas AM, Brightman L, Sukal S, et al. Successful treatment of acneiform scarring with CO2 ablative fractional resurfacing［J］. Lasers Surg Med, 2008,40（6）:381⁃386. doi: 10.1002/lsm.20659.
|
| ［7］ |
Shamsaldeen O, Peterson JD, Goldman MP. The adverse events of deep fractional CO2: a retrospective study of 490 treatments in 374 patients［J］. Lasers Surg Med, 2011,43（6）:453⁃456. doi: 10.1002/lsm.21079.
|
| ［8］ |
Abad⁃Casintahan F, Chow SK, Goh CL, et al. Frequency and characteristics of acne⁃related post⁃inflammatory hyperpigmentation［J］. J Dermatol, 2016,43（7）:826⁃828. doi: 10.1111/1346⁃8138.13263.
|
| ［9］ |
Akinboro AO, Ezejiofor OI, Olanrewaju FO, et al. The impact of acne and facial post⁃inflammatory hyperpigmentation on quality of life and self⁃esteem of newly admitted Nigerian undergraduates［J］. Clin Cosmet Investig Dermatol, 2018,11:245⁃252. doi: 10.2147/CCID.S158129.
|
| ［10］ |
安庆, 栾琪. 炎症后色素沉着的治疗进展［J］. 中国激光医学杂志, 2020,29（5）:314⁃318. doi: 10.13480/j.issn1003⁃9430. 2020.0314.
|
| ［11］ |
Kim JH, Seok JK, Kim YM, et al. Identification of small peptides and glycinamide that inhibit melanin synthesis using a positional scanning synthetic peptide combinatorial library［J］. Br J Dermatol, 2019,181（1）:128⁃137. doi: 10.1111/bjd.17634.
|
| ［12］ |
Boo YC. Up⁃ or downregulation of melanin synthesis using amino acids, peptides, and their analogs［J］. Biomedicines, 2020,8（9）:322. doi: 10.3390/biomedicines8090322.
|
| ［13］ |
Lee HK, Ha JW, Hwang YJ, et al. Identification of L⁃cysteinamide as a potent inhibitor of tyrosinase⁃mediated dopachrome formation and eumelanin synthesis［J］. Antioxidants （Basel）, 2021,10（8）:1202. doi: 10.3390/antiox10081202.
|
| ［14］ |
Chaowattanapanit S, Silpa⁃Archa N, Kohli I, et al. Postinflammatory hyperpigmentation: a comprehensive overview: treatment options and prevention［J］. J Am Acad Dermatol, 2017,77（4）:607⁃621. doi: 10.1016/j.jaad.2017.01.036.
|
| ［15］ |
Park JY, Park JH, Kim SJ, et al. Two histopathological patterns of postinflammatory hyperpigmentation: epidermal and dermal［J］. J Cutan Pathol, 2017,44（2）:118⁃124. doi: 10.1111/cup. 12849.
|
| ［16］ |
Tan MG, Kim WB, Jo CE, et al. Topical treatment for postinflammatory hyperpigmentation: a systematic review［J］. J Dermatolog Treat, 2022,33（5）:2518⁃2526. doi: 10.1080/0954 6634.2021.1981814.
|
| ［17］ |
Kalasho BD, Minokadeh A, Zhang⁃Nunes S, et al. Evaluating the safety and efficacy of a topical formulation containing epidermal growth factor, tranexamic acid, vitamin C, arbutin, niacinamide and other ingredients as hydroquinone 4% alternatives to improve hyperpigmentation: a prospective, randomized, controlled split face study［J］. J Cosmet Sci, 2020,71（5）:263⁃290.
|
| ［18］ |
Boo YC. Arbutin as a skin depigmenting agent with antimelanogenic and antioxidant properties［J］. Antioxidants （Basel）, 2021,10（7）:1129. doi: 10.3390/antiox10071129.
|
| ［19］ |
Bierman JC, Laughlin T, Tamura M, et al. Niacinamide mitigates SASP⁃related inflammation induced by environmental stressors in human epidermal keratinocytes and skin［J］. Int J Cosmet Sci, 2020,42（5）:501⁃511. doi: 10.1111/ics.12651.
|
| ［20］ |
Boo YC. Mechanistic basis and clinical evidence for the applications of nicotinamide （niacinamide） to control skin aging and pigmentation［J］. Antioxidants （Basel）, 2021,10（8）:1315. doi: 10.3390/antiox10081315.
|
| ［21］ |
Lindgren AL, Austin AH, Welsh KM. The use of tranexamic acid to prevent and treat post⁃inflammatory hyperpigmentation［J］. J Drugs Dermatol, 2021,20（3）:344⁃345. doi: 10.36849/JDD.5622.
|
| ［22］ |
Puaratanaarunkon T, Asawanonda P. A randomized, double blinded, split⁃face study of the efficacy of using a broad spectrum sunscreen with anti⁃inflammatory agent to reduce post inflammatory hyperpigmentation after picosecond laser［J］. Clin Cosmet Investig Dermatol, 2022,15:331⁃337. doi: 10.2147/CCID.S355329.
|
| ［23］ |
Juhasz M, Levin MK. The role of systemic treatments for skin lightening［J］. J Cosmet Dermatol, 2018,17（6）:1144⁃1157. doi: 10.1111/jocd.12747.
|
| ［24］ |
Callender VD, St Surin⁃Lord S, Davis EC, et al. Postinflammatory hyperpigmentation: etiologic and therapeutic considerations［J］. Am J Clin Dermatol, 2011,12（2）:87⁃99. doi: 10.2165/11536930⁃000000000⁃00000.
|
| ［25］ |
中华医学会皮肤性病学分会, 中国医师协会皮肤科医师分会, 中国中西医结合学会皮肤性病专业委员会. 中国化学剥脱术临床应用专家共识（2022）［J］. 中华皮肤科杂志, 2022,55（11）:949⁃955. doi: 10.35541/cjd.20220309.
|
| ［26］ |
Conforti C, Zalaudek I, Vezzoni R, et al. Chemical peeling for acne and melasma: current knowledge and innovations［J］. G Ital Dermatol Venereol, 2020,155（3）:280⁃285. doi: 10.23736/S0392⁃0488.19.06425⁃3.
|
| ［27］ |
Sowash M, Alster T. Review of laser treatments for post⁃inflammatory hyperpigmentation in skin of color［J］. Am J Clin Dermatol, 2023,24（3）:381⁃396. doi: 10.1007/s40257⁃023⁃00759⁃7.
|
| ［28］ |
Vachiramon V, Namasondhi A, Anuntrangsee T, et al. A single⁃blinded, randomized, controlled trial comparing efficacy between low⁃fluence alexandrite 755⁃nm picosecond laser and low⁃fluence neodymium⁃doped yttrium aluminum garnet （Nd:YAG） 1064⁃nm picosecond laser for the treatment of ultraviolet B⁃induced hyperpigmentation［J］. J Cosmet Dermatol, 2022,21（3）:1036⁃1044. doi: 10.1111/jocd.14591.
|
| ［29］ |
Rivers JK, Zarbafian M, Vestvik B, et al. Minocycline⁃induced hyperpigmentation: rapid resolution after 755 nm alexandrite picosecond laser treatment［J］. J Cosmet Laser Ther, 2020,22（2）:96⁃99. doi: 10.1080/14764172.2020.1740275.
|
| ［30］ |
Katz TM, Goldberg LH, Firoz BF, et al. Fractional photothermolysis for the treatment of postinflammatory hyperpigmentation［J］. Dermatol Surg, 2009,35（11）:1844⁃1848. doi: 10.1111/j.1524⁃4725.2009.01303.x.
|
| ［31］ |
Oram Y, Akkaya AD. Refractory postinflammatory hyperpigmentation treated fractional CO2 laser［J］. J Clin Aesthet Dermatol, 2014,7（3）:42⁃44.
|
| ［32］ |
杨鑫, 陆禹河, 毛银雪, 等. 中药美白活性成分及作用机制研究［J］. 食品与药品, 2021,23（6）:后插2⁃后插8. doi: 10.3969/j.issn.1672⁃979X.2021.06.020.
|
| ［33］ |
王玉华, 林岫, 付丽佳, 等. 中药防治放射性皮肤损伤的研究进展［J］. 中华放射医学与防护杂志, 2014,34（4）:314⁃317. doi: 10.3760/cma.j.issn.0254⁃5098.2014.04.020.
|
| ［34］ |
Eichenfield DZ, Sprague J, Eichenfield LF. Management of acne vulgaris: a review［J］. JAMA, 2021,326（20）:2055⁃2067. doi: 10.1001/jama.2021.17633.
|
| ［35］ |
Kashetsky N, Feschuk A, Pratt ME. Post⁃inflammatory hyperpigmentation: a systematic review of treatment outcomes［J］. J Eur Acad Dermatol Venereol, 2024,38（3）:470⁃479. doi: 10.1111/jdv.19566.
|
| ［36］ |
中华医学会医学美学与美容学分会皮肤美容学组. 修复皮肤屏障功能的专家共识［J］. 中华医学美学美容杂志, 2022,28（1）:1⁃4. doi: 10.3760/cma.j.issn.1671⁃0290.2022.01.001.
|
| ［37］ |
Goh CL, Kang HY, Morita A, et al. Awareness of sun exposure risks and photoprotection for preventing pigmentary disorders in Asian populations: survey results from three Asian countries and expert panel recommendations［J］. Photodermatol Photoimmunol Photomed, 2024,40（1）:e12932. doi: 10.1111/phpp.12932.
|
| ［38］ |
Yan Y, Chen H, Chen L, et al. Consensus of Chinese experts on protection of skin and mucous membrane barrier for health⁃care workers fighting against coronavirus disease 2019［J］. Dermatol Ther, 2020,33（4）:e13310. doi: 10.1111/dth.13310.
|
